Clinical Trial Update: Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral Neuropathy [Phase 2]

View source ↗

Summary

This document reports on a Phase 2 trial of TRO19622 for chemotherapy-induced peripheral neuropathy, with the study status shown as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• TRO19622

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chemotherapy-Induced Peripheral Neuropathy | Phase 2 | Status: COMPLETED